HH BIOTECHNOLOGY HOLDINGS CO·3/A

Jan 23, 4:40 PM ET

HH BIOTECHNOLOGY HOLDINGS CO 3/A

3/A · HH BIOTECHNOLOGY HOLDINGS CO · Filed Jan 23, 2017

Insider Transaction Report

Form 3/AAmended
Period: 2016-09-09
Wang Lirong
Chief Financial Officer
Holdings
  • Common Stock

    91,024

Documents

1 file
  • 3
    primary_doc.xml

    PRIMARY DOCUMENT